Abstract

Progress in gene drive research has engendered a lively discussion about community engagement and the ethical standards the work hinges on. While there is broad agreement regarding ethical principles and established best practices for conducting clinical public health research, projects developing area-wide vector control technologies and initiating ambitious engagement strategies raise specific questions: who to engage, when to engage, and how? When responding to these fundamental questions, with few best practices available for guidance, projects need to reflect on and articulate the ethical principles that motivate and justify their approach. Target Malaria is a not-for-profit research consortium that aims to develop and share malaria control and elimination technology. The consortium is currently investigating the potential of a genetic technique called gene drive to control populations of malaria vectoring mosquito species Anopheles gambiae. Due to the potentially broad geographical, environmental impact of gene drive technology, Target Malaria has committed to a robust form of tailored engagement with the local communities in Burkina Faso, Mali, and Uganda, where research activities are currently taking place. This paper presents the principles guiding Target Malaria’s engagement strategy. Herein the authors (i) articulate the principles; (ii) explain the rationale for selecting them; (iii) share early lessons about the application of the principles. Since gene drive technology is an emerging technology, with few best practices available for guidance, the authors hope by sharing these lessons, to add to the growing literature regarding engagement strategies and practices for area-wide vector control, and more specifically, for gene drive research.

Highlights

  • In 2021, the World Health Organization (WHO) published the 2nd edition of its guidance for testing genetically modified mosquitoes [1]

  • A major portion of that report was dedicated to ethical considerations, stressing and the importance of responsible community engagement

  • This paper aims to do the same by articulating the ethical principles guiding the design and implementation of Target Malaria’s engagement strategy

Read more

Summary

Background

In 2021, the World Health Organization (WHO) published the 2nd edition of its guidance for testing genetically modified mosquitoes [1]. The initial phases involve using nongene drive strains of genetically modified mosquitoes [12], which allow for iterative development, integrating learning from previous modified strains to the phase This modus operandi leaves room for piloting the engagement strategy, developed in an early implementation stage according to principles presented here. Papers and guidelines analysing ethical obligations inherent to engagement practices [1, 18, 23] have primarily focused on the question of consent to the release of genetically modified mosquitoes [13, 15, 18, 20, 26, 27] They suggested that engagement should include a greater degree of partnership than previously seen between researchers and communities living in the research area [3, 14, 18, 23, 24]. These principles are: 1. Prioritize engagement with the most ethically relevant groups

Conduct engagement in the spirit and form of codevelopment
Findings
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call